Immunotherapy of hypersensitivity to hymenoptera venom.
Insect sting allergy is a common condition with a risk of life-threatening anaphylaxis. After a severe reaction, the fear of being restung can significantly reduce quality of life. Venom immunotherapy (VIT) is a highly effective treatment of the underlying type I-sensitisation. This review addresses the mechanisms of immune modulation by VIT and outlines current clinical application. Although highly effective in the majority of patients, VIT fails in a few individuals. It can also cause systemic allergic side effects, restricting its application to physicians trained in the treatment of anaphylaxis. This review discusses several new strategies to overcome these problems, which are presently a promising focus of research. These include the use of new adjuvants, of recombinant and genetically engineered venom allergens, as well as vaccination with peptides.
Roers
Axel
A
Department of Dermatology, University of Cologne, Josef Stelzmann Str. 9, 50931 Cologne, Germany.
Hunzelmann
Nicolas
N
D000818:Animals; D001180:Arthropod Venoms / Q000276:immunology / Q000627:therapeutic use*; D006801:Humans; D006927:Hymenoptera / Q000276:immunology*; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D007167:Immunotherapy / Q000379:methods*; D007299:Insect Bites and Stings / Q000276:immunology / Q000628:therapy*
D001180:Arthropod Venoms